|
|
肺纤维化和肺癌疾病共同信号通路及作用机制研究进展 |
任善发, 崔梦奇, 暴嘉丽, 王明, 肖婷, 周红刚 |
南开大学药物化学生物学国家重点实验室, 天津 300381 |
|
[1] Mori Y,Kondoh Y.What parameters can be used to identify early idiopathic pulmonary fibrosis[J].Respir Investig,2021,59(1):53~65. [2] Wei P,Xie Y,Abel PW,Huang Y,et al.Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis[J].Cell Death Dis,2019,10(9):670. [3] Weiskirchen R,Weiskirchen S,Tacke F.Organ and tissue fibrosis:molecular signals,cellular mechanisms and translational implications[J].Mol Aspects Med,2019,65:2~15. [4] Tang Z,Ding Y,Shen Q,Zhang C,et al.KIAA1199 promotes invasion and migration in non-small-cell lung cancer (NSCLC) via PI3K-Akt mediated EMT[J].Mol Med (Berl),2019,97(1):127~140. [5] Phiboonchaiyanan PP,Busaranon K,Ninsontia C,Chanvorachote P.Benzophenone-3 increases metastasis potential in lung cancer cells via epithelial to mesenchymal transition[J].Cell Biol Toxicol,2017,33(3):251~261. [6] Gerarduzzi C,Di Battista JA.Myofibroblast repair mechanisms post-inflammatory response:a fibrotic perspective[J].Inflamm Res,2017,66(6):451~465. [7] Koval M,Billaud M,Straub AC,Johnstone SR,et al.Spontaneous lung dysfunction and fibrosis in mice lacking connexin 40 and endothelial cell connexin 43[J].Am Pathol,2011,178(6):2536~2546. [8] Chen R,Chen Y,Yuan Y,Zou X,et al.Cx43 and AKAP95 regulate G1/S conversion by competitively binding to cyclin E1/E2 in lung cancer cells[J].Thorac Cancer,2020,11(6):1594~1602. [9] Wu D,Huo C,Jiang S,Huang Y,et al.Exostosin1 as a novel prognostic and predictive biomarker for squamous cell lung carcinoma:A study based on bioinformatics analysis[J].Cancer Med,2021,10(8):2787~2801. [10] Hollenberg MD,Oikonomopoulou K,Hansen KK,Saifeddine M,et al.Kallikreins and proteinase-mediated signaling:proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer[J].Biol Chem,2008,389(6):643~651. [11] Pritchard A,Tousif S,Wang Y,et al.Lung tumor cell-derived exosomes promote M2 macrophage polarization[J].Cells,2020,9(5):1303. [12] Kamio K,Azuma A,Matsuda K,et al.Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation[J].Respir Res,2018,19(1):71. [13] Katoh M.Multilayered prevention and treatment of chronic inflammation,organ fibrosis and cancer associated with canonical WNT/β-catenin signaling activation (Review)[J].Int Mol Med,2018,42(2):713~725. [14] Stewart DJ.Wnt signaling pathway in non-small cell lung cancer[J].Natl Cancer Inst,2014,106(1):356. [15] Mailleux AA,Moshai EF,Crestani B.Sonic Hedgehog signaling in pulmonary fibrosis:a spiky issue[J].Am Physiol Lung Cell Mol Physiol,2013,304(6):391~393. [16] Giroux-Leprieur E,Costantini A,Ding VW,He B.Hedgehog signaling in lung cancer:from oncogenesis to cancer treatment resistance[J].Int Mol Sci,2018,19(9):2835. [17] Hussain M,Xu C,Ahmad M,Yang Y,et al.Notch signaling:linking embryonic lung development and asthmatic airway remodeling[J].Mol Pharmacol,2017,92(6):676~693. [18] Hu X,Xu Q,Wan H,Hu Y,et al.PI3K-Akt-mTOR/PFKFB3 pathway mediated lung fibroblast aerobic glycolysis and collagen synthesis in lipopolysaccharide-induced pulmonary fibrosis[J].Lab Invest,2020,100(6):801~811. [19] Tan AC.Targeting the PI3K/Akt/mTOR pathway in non-small cell lung cancer (NSCLC)[J].Thorac Cancer,2020,11(3):511~518. |
[1] |
黄符香, 高长胜, 张爽, 王文军, 宋歌. 右美托咪定基于PI3K/AKT/CREB信号通路对肝脏缺血再灌注损伤大鼠干预作用研究[J]. 河北医学, 2022, 28(2): 189-194. |
[2] |
许刚, 宋其义, 於丽乔. Per1基因对口腔鳞癌细胞增殖侵袭和迁移的影响[J]. 河北医学, 2022, 28(2): 220-224. |
[3] |
李新军, 钟敏华, 吴展陵, 曹玲莉, 邱琦, 涂平华, 汪娜娜, 彭闪闪, 高飞. miR-145-5p通过调节PHB2基因发挥对非小细胞肺癌细胞A549增殖迁移的影响[J]. 河北医学, 2021, 27(9): 1418-1422. |
[4] |
李传贵, 刘晓城, 张新慧, 周桂娟, 朱月香. CT灌注评估NP化疗联合鸦胆子油乳治疗非小细胞肺癌的疗效[J]. 河北医学, 2021, 27(9): 1508-1511. |
[5] |
陈丽君, 覃世运, 刘旭初, 陈钟勇. 吉西他滨或多西他赛联合顺铂化疗治疗NSCLC对患者凝血功能 CYFRA21-1 CA199的影响[J]. 河北医学, 2021, 27(9): 1566-1571. |
[6] |
徐晨, 王胜, 李春颖. 安罗替尼治疗晚期非小细胞肺癌的系统评价[J]. 河北医学, 2021, 27(8): 1265-1271. |
[7] |
马宋坤, 张伟林, 马志平, 赵淑灿. 肺气肿与非小细胞肺癌患者放疗后放射性肺炎的相关影响因素[J]. 河北医学, 2021, 27(8): 1353-1358. |
[8] |
丁灵芝, 罗向军, 陈伟伟, 杨爱珍. miR-497 CCNE1在非小细胞肺癌组织中的表达及与预后的关系[J]. 河北医学, 2021, 27(6): 952-957. |
[9] |
周易, 李火平, 夏光明, 周帆, 金朝霞, 张慧. 黄芪注射液联合阿托伐他汀对急性肺损伤大鼠肺纤维化及细胞黏附功能的影响[J]. 河北医学, 2021, 27(5): 719-723. |
[10] |
罗立, 熊沿, 王慧, 张剑, 聂晓红. 支气管肺泡灌洗液和血清中TGF-β IFN-γ水平与特发性肺纤维化的关系[J]. 河北医学, 2021, 27(5): 762-767. |
[11] |
李晓华, 李洁, 唐军伟. 外周血循环肿瘤细胞和肿瘤标志物在评估老年非小细胞肺癌患者化疗后疗效中的价值[J]. 河北医学, 2021, 27(5): 779-785. |
[12] |
彭非, 卢经伟, 李勇, 张艳霞. 沉默ADAM17抑制肺癌细胞sMICA分泌促进NK细胞的抗肿瘤免疫效应[J]. 河北医学, 2021, 27(4): 529-534. |
[13] |
范成龙, 吴勇, 周鑫, 王体芬. PCIA联合TPVB或ESPB对肺癌开胸手术镇痛效果血流动力学及血清炎性因子影响[J]. 河北医学, 2021, 27(4): 567-571. |
[14] |
周晓瑜, 常杰, 王二晓, 张静静, 樊蕊. CDKN2A基因在肺癌组织中表达及其临床意义[J]. 河北医学, 2021, 27(4): 654-659. |
[15] |
赵洁, 宁鹏, 刘海明. 埃克替尼片联合SBRT治疗对NSCLC血清肿瘤标志物的影响[J]. 河北医学, 2021, 27(4): 697-700. |
|
|
|
|